T002: Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group

ABSTRACT:

SUBMITTER: Borchmann P 

PROVIDER: S-EPMC9621550 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature